Page last updated: 2024-10-23

bisindolylmaleimide i and Diabetes Mellitus

bisindolylmaleimide i has been researched along with Diabetes Mellitus in 2 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angulo, J1
Cuevas, P1
Fernández, A1
Allona, A1
Moncada, I1
Martín-Morales, A1
La Fuente, JM1
de Tejada, IS1
Kuboki, K1
Jiang, ZY1
Takahara, N1
Ha, SW1
Igarashi, M1
Yamauchi, T1
Feener, EP1
Herbert, TP1
Rhodes, CJ1
King, GL1

Other Studies

2 other studies available for bisindolylmaleimide i and Diabetes Mellitus

ArticleYear
Enhanced thromboxane receptor-mediated responses and impaired endothelium-dependent relaxation in human corpus cavernosum from diabetic impotent men: role of protein kinase C activity.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:2

    Topics: Alprostadil; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus; Endothelium; Erectile Dysfu

2006
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.
    Circulation, 2000, Feb-15, Volume: 101, Issue:6

    Topics: Animals; Cattle; Cells, Cultured; Diabetes Mellitus; Endothelium, Vascular; Enzyme Inhibitors; Gene

2000